Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   IRANIAN JOURNAL OF CLINICAL INFECTIOUS DISEASES   2007 , Volume 2 , Number 2; Page(s) 55 To 56.
 
Paper: 

THE QUEST FOR AN HIV VACCINE

 
 
Author(s):  GOUDARZI HOSSEIN*
 
* INFECTIOUS DISEASES AND TROPICAL MEDICINE RESEARCH CENTER, SHAHID BEHESHTI MEDICAL UNIVERSITY, TEHRAN, IRAN
 
Abstract: 

Despite the international community's best efforts the HIV pandemic countries unabated. In 2006, more than 39 million people were living with HIV worldwide. Over four million people became newly infected with HIV and an estimated 2.8 million lost their lives due to AIDS. On average, people require life-saving antiretroviral treatment (ARVs) 7-10 years after becoming infected. While there has been recent progress in increasing access to treatment and prevention programs, HIV continues to outplace the global response with at least 80% of those in clinical need of ARVs worldwide not receiving them. Further, while decline in national HIV prevalence has occurred in, for example, some sub-saharan African countries, these trends are not strong or widespread enough to have a major impact on the epidemics.

 
Keyword(s): 
 
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

GOUDARZI, H. (2007). THE QUEST FOR AN HIV VACCINE. IRANIAN JOURNAL OF CLINICAL INFECTIOUS DISEASES, 2(2), 55-56. https://www.sid.ir/en/journal/ViewPaper.aspx?id=168623



Vancouver: Copy

GOUDARZI HOSSEIN. THE QUEST FOR AN HIV VACCINE. IRANIAN JOURNAL OF CLINICAL INFECTIOUS DISEASES. 2007 [cited 2021October17];2(2):55-56. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=168623



IEEE: Copy

GOUDARZI, H., 2007. THE QUEST FOR AN HIV VACCINE. IRANIAN JOURNAL OF CLINICAL INFECTIOUS DISEASES, [online] 2(2), pp.55-56. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=168623.



 
  pdf-File
Yearly Visit 44
 
 
Latest on Blog
Enter SID Blog